Stay updated on GEMINI 2 Tolebrutinib in RMS Clinical Trial
Sign up to get notified when there's something new on the GEMINI 2 Tolebrutinib in RMS Clinical Trial page.

Latest updates to the GEMINI 2 Tolebrutinib in RMS Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedAdded two location entries: Gūrgaon, India, 122001 and Gūrgaon, India, 122002. Removed Gurgaon, India, 122001 and Gurgaon, India, 122002.SummaryDifference0.0%

- Check20 days agoChange DetectedAdded Gurgaon, India, 122001 and Gurgaon, India, 122002 as new study locations. Updated the page revision from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check27 days agoChange DetectedThe Indian site entries 122001 and 122002 changed from Gurgaon to Gūrgaon (diacritic included); this is a spelling/diacritic update to the same locations.SummaryDifference0.1%

- Check34 days agoChange DetectedStandardized the city name from Gūrgaon to Gurgaon for two Indian sites (122001 and 122002) in the locations section.SummaryDifference0.0%

- Check55 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check62 days agoChange DetectedGurgaon location entries were updated to the diacritic form 'Gūrgaon' (two entries). The page revision tag changed from v3.4.0 to v3.4.1.SummaryDifference0.1%

Stay in the know with updates to GEMINI 2 Tolebrutinib in RMS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GEMINI 2 Tolebrutinib in RMS Clinical Trial page.